Medical Device Watch: Boston Scientific shares slid after it flagged declining standalone Watchman usage as procedures increasingly get bundled with other heart treatments, setting expectations for flatter growth. Long COVID Research: A Mass General Brigham study using AI-linked medical records estimates long COVID at about 16% of infected adults—far higher than federal estimates—raising the stakes for screening and care. Cancer Screening Upgrade: The American Cancer Society added a blood test option for colorectal cancer screening for people who won’t do stool tests or colonoscopies, though it’s less sensitive for early disease. Biotech Leadership: Retension Pharmaceuticals named a new CMO and CFO as it advances its hypertension drug through Phase 2b. Protein Design Breakthrough: Biohub released an updated ESM protein model family to improve binder design and protein function mapping for faster therapeutic discovery. AI Governance in Practice: A Tax Notes investigation highlights how bias in state AI systems can skew audit selection, with California and New York as case studies. Local Tech & Public Safety: Cambridge police union criticized ending ShotSpotter, arguing it could slow gunfire response; meanwhile, Marlboro school bus drivers and monitors struck. Robotics Trust Layer: FORT Robotics acquired Mapless AI to expand remote supervision and active safety for supervised autonomy. Massachusetts Policy Push: A bill would let bars and restaurants stay open until 3 a.m. during the World Cup and allow designated public drinking areas.